Significant investment in multiple high throughput systems provides accelerated and robust development and manufacturing. Thermo fisher scientific increased its manufacturing capacity in st Louis to support biological therapies manufacturing for rare diseases. Thermo fisher got into the contract manufacturing business back in 2017 with a blockbuster $7.2 billion deal to buy patheon, one of the largest contract manufacturers in the world at the time. The $50 million investment, spanning 62,000 square feet, will add 80 new technical jobs and substantially increase thermo fisher’s ability to meet the clinical and commercial manufacturing needs of its growing client base This expansion is a near doubling of the production capacity.
Thermo fisher scientific expanded its manufacturing capacity in st Louis to support biologic therapies for diseases ranging from cancers to auto immune conditions to rare genetic disorders. In 2021, thermo fisher scientific invested $82.5 million to expand our st Louis biologics site, adding two new manufacturing suites and $15 million in advanced equipment—including the. The us$50 million (€43 million) expansion effectively doubles the firm’s global biomanufacturing capacity. The new bioprocessing collaboration center (bcc) in st
OPEN
